Another PBM Favors Sandoz And Boehringer On Adalimumab

Humira Rivals Hyrimoz And Cyltezo Get Preferred Status From Express Scripts

 
• By Dave Wallace

Express Scripts has followed Optum Rx’s lead by awarding preferred status to Humira biosimilars from Sandoz and Boehringer Ingelheim.

Express Scripts Headquarters
Express Scripts has awarded preferred status to Sandoz and Boehringer’s biosimilars • Source: Shutterstock

More from Biosimilars

More from Products